VINZENZ GRUPPE
     
 

ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

Dumonceau, Jean-Marc, Kapral, Christine, Aabakken, Lars, Papanikolaou, Ioannis S, Tringali, Andrea, Vanbiervliet, Geoffroy, Beyna, Torsten, Dinis-Ribeiro, Mario, Hritz, Istvan, Mariani, Alberto, Paspatis, Gregorios, Radaelli, Franco, Lakhtakia, Sundeep, Veitch, Andrew M and van Hooft, Jeanin E (2020) ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 52 (2). pp. 127-149. ISSN 1438-8812

Full text not available from this repository.

Abstract

PROPHYLAXIS 1:  ESGE recommends routine rectal administration of 100 mg of diclofenac or indomethacin immediately before endoscopic retrograde cholangiopancreatography (ERCP) in all patients without contraindications to nonsteroidal anti-inflammatory drug administration.Strong recommendation, moderate quality evidence. 2:  ESGE recommends prophylactic pancreatic stenting in selected patients at high risk for post-ERCP pancreatitis (inadvertent guidewire insertion/opacification of the pancreatic duct, double-guidewire cannulation).Strong recommendation, moderate quality evidence. 3:  ESGE suggests against routine endoscopic biliary sphincterotomy before the insertion of a single plastic stent or an uncovered/partially covered self-expandable metal stent for relief of biliary obstruction.Weak recommendation, moderate quality evidence. 4:  ESGE recommends against the routine use of antibiotic prophylaxis before ERCP.Strong recommendation, moderate quality evidence. 5:  ESGE suggests antibiotic prophylaxis before ERCP in the case of anticipated incomplete biliary drainage, for severely immunocompromised patients, and when performing cholangioscopy.Weak recommendation, moderate quality evidence. 6:  ESGE suggests tests of coagulation are not routinely required prior to ERCP for patients who are not on anticoagulants and not jaundiced.Weak recommendation, low quality evidence. TREATMENT 7:  ESGE suggests against salvage pancreatic stenting in patients with post-ERCP pancreatitis.Weak recommendation, low quality evidence. 8:  ESGE suggests temporary placement of a biliary fully covered self-expandable metal stent for post-sphincterotomy bleeding refractory to standard hemostatic modalities.Weak recommendation, low quality evidence. 9:  ESGE suggests to evaluate patients with post-ERCP cholangitis by abdominal ultrasonography or computed tomography (CT) scan and, in the absence of improvement with conservative therapy, to consider repeat ERCP. A bile sample should be collected for microbiological examination during repeat ERCP.Weak recommendation, low quality evidence.
Item Type: Article
Depositing User: Kornelia Söllinger
Date Deposited: 12 Apr 2022 08:04
Last Modified: 12 Apr 2022 08:04
URI: https://eprints.vinzenzgruppe.at/id/eprint/9204

Actions (login required)

View Item
View Item